當(dāng)前位置：   首頁 > 需求大廳

 >  特色服務(wù) 

 >  信息服務(wù) 

1、P. A. Prajapati and M. M. Patel, “Formulation and in vitro evaluation of atropine sulphate viscous ocular solutions for the mydriatic and cycloplegic effect,”?International Journal of Pharmaceutical and Applied Sciences, vol. 1, no. 2, pp. 70–78, 2010.?View at Google Scholar 2、D. S. Satya, K. P. Suria, and P. P. Muthu, “Advanced approaches and evaluation of ocular drug delivery system,”?American Journal of PharmTech Research, vol. 1, no. 4, pp. 72–92, 2011.?View at Google Scholar 3、B. K. Nanjwade, D. B. Sonaje, and F. V. Manvi, “In vitro—in vivo?release of ciprofloxacin from ophthalmic formulations,”?International Journal of Pharmacy and Biotechnology, vol. 1, no. 1, pp. 23–28, 2011.?View at Google Scholar 4、Physicochemical properties and stability of nicorandil By Nagai, Hiroshi; Koizumi, Ikue; Haneda, Masatoshi; Imai, Toshikatsu; Kikuchi, Mineo; Shiba, Motoharu From Iyakuhin Kenkyu (1983), 14(6), 968-79. Language: Japanese, Database: CAPLUS 5、Sobean oil partially hydrogenated 最新德國(guó)藥典   [更多]

1、https://www.sciencedirect.com/science/article/pii/S0022354917307177 2、Justus Liebigs Annalen der Chemie, 1907, vol. 351, p. 319 3、Efficacy and tolerability of amlodipine in patients with stable angina pectoris: an open-label, multicenter trial Volume 59, Issue 4, April 1998, Pages 215-222 4、Efficacy and safety of perindopril arginine + amlodipine in hypertension Journal of the American Society of Hypertension Volume 9, Issue 4, April 2015, Pages 266-274 5、Sprifermin shows cartilage-protective effects in knee OA 6、Justus Liebigs Annalen der Chemie, 1907, vol. 351, p. 319 7、Quantitation of cytokine levels in skin graft donor site wound fluid. Grayson LS1, Hansbrough JF, Zapata-Sirvent RL, Dore CA, Morgan JL, Nicolson MA. 8、Preparation of tadalafil analogues as antiparasitic agents 9、https://academic.oup.com/mmy/article-abstract/57/2/181/4909416?redirectedFrom=fulltext 10、https://jamanetwork.com/journals/jamadermatology/article-abstract/557354 11、Bioequivalence assessment of Fumatifen? tablet to Zaditen? tablet (ketotifen fumarate 1 mg) by liquid chromatography tandem mass spectrometry 12、Pharmacokinetics of ketotifen after oral administration to healthy male subjects 13、Optimal medical management of peripheral arterial disease. Rice TW, Lumsden AB. Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. Review. 14、Treatment of small hepatocellular carcinomas 15、CIMETIDINE, THE IMMUNE SYSTEM, AND CANCER 16、Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial 17、https://www.karger.com/Article/Abstract/236401 18、Reaction of enamines and mediated anodic oxidation of carbohydrates with the 2,2,6,6-tetramethylpiperidine-1-oxoammonium ion (TEMPO+) Electrochimica Acta, Volume 50, Issues 25–26, 5 September 2005, Pages 4956-4972 19、An improved HPLC method for determination of nifuratel in human plasma and its application to pharmacokinetics studies XL   [更多]

根據(jù)已知省份、城市的醫(yī)院銷售數(shù)據(jù)樣本，根據(jù)樣本數(shù)據(jù)如何計(jì)算醫(yī)院銷售數(shù)據(jù)在全國(guó)的銷售量、銷售額？ 放大規(guī)則提供相關(guān)原理，思路，計(jì)算中所需要的樣本變量（字段，如：如“某藥品的藥品銷售額”與“樣本對(duì)于省份”，“樣本城市數(shù)量”、“樣本醫(yī)院數(shù)量”、“樣本醫(yī)院等級(jí)比例”等的關(guān)系），以及相關(guān)規(guī)格參數(shù)以及參數(shù)計(jì)算的方式，具體細(xì)節(jié)可私下溝通。   [更多]

1.Arzneimittel Forschung/Drug research 1986 36(2)，p291-303. 2.The use of antithrombotic drugs in artery disease 3. Jonassen IB, Havelund S, Ribel U, et al. Insulin Degludec is a new generation ultra-long acting basal insulin with a unique mechanism of protraction based on multi-hexamer ormation [J]. Diabetes, 2010, 59(Suppll): All(39-OR). 4.Korsatko S, Deller S, Zahiragic S, et al. Ultra-long-acting insulin degludec: two different formulations (U100 and U200) are bioequivalent and show similar pharmacodynamics [abstract no. 2349-PO]. Diabetes. 2011;60 Suppl:A624. 5.Technology Reports of the Osaka University, , vol. 7, p. 177,182。   [更多]

1、Drugs Fut 1989, 14(9): 875 ISSN 0377-8282 Copyright Clarivate Analytics CCC: 0377-8282 DOI: 10.1358/dof.1989.014.09.103408 2、Dionne, G. (BioChem Pharma Inc.); 1,3-Oxathiolane nucleoside analogues. EP 0526253; JP 1995500317; US 5538975; WO 9303027 . 3、Hoshi, A.; Casta?er, J.; Capecitabine. Drugs Fut 1996, 21, 4, 358 4、Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1997, vol. 36, # 9, p. 816 - 818 5、DETERMINATION OF CLENBUTEROL HYDROCHLORIDE BY SEQUENTIAL INJECTION ANALYSIS COUPLED WITH CHEMILUMINESCENCE DETECTION 6、[Bioanalytic examination and pharmacokinetics of captopril. Bioequivalence studies of different captopril-containing Tensiomin preparations]. 7、Agrati A. M., De Bartolo G., Palmieri G., Minerva Med., 83, 533-536(1992) 8、Dawes J., Hodson B. A., Pepper D. S., Thromb. Haemost, 62, 945-949(1989) 9、with mercury(II) diacetate,trifluoroacetic acid . Acta Chimica Hungarica 1986 vol.122 3-4 p261-272   [更多]

求歐洲藥典全套9.2英文版   [更多]

藥物研發(fā)中心全套質(zhì)量管理體系文件，越詳細(xì)越好，價(jià)格可談！   [更多]

1.論批生產(chǎn)記錄設(shè)計(jì)的有效性對(duì)產(chǎn)品質(zhì)量追溯的影響——以公司內(nèi)膠囊及片劑產(chǎn)品批生產(chǎn)記錄為例 2.Federal Health bulletin 4（1961）12:189 需要這個(gè)文獻(xiàn) 3.Morton RF, et al. Studies on the absorption, diffusion, and excretion of cycloserine. Antibiot Annu 1955-56; 3: 169-72. 4.Acta Gastroenterol Belg.1969,32（10）：771-777 A NEW ANTISPASMODIC DRUG IN THE TREATMENT OF BILIARY AND INTESTINAL DISCASCS:A CLINICAL TEST. 5.a process for preparing (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one https://priorart.ip.com/IPCOM/000238343   [更多]

簡(jiǎn)介：藥智人才是最專業(yè)的醫(yī)藥產(chǎn)業(yè)招聘平臺(tái)，與許多醫(yī)藥行業(yè)的知名企業(yè)都有合作，職位種類豐富，崗位更專業(yè)~ 賺取賞金規(guī)則（活動(dòng)時(shí)間：5月13日-5月17日）： 1.免費(fèi)注冊(cè)/登錄藥智人才（https://job.yaozh.com/），上傳簡(jiǎn)歷： 簡(jiǎn)歷完善度≥80 可獲得50元賞金； 2.簡(jiǎn)歷完成后，并截圖藥智人才簡(jiǎn)歷板塊的完善度提交審核，并且備注藥智人才的用戶名/注冊(cè)手機(jī)信息； 3.審核通過后，賞金會(huì)在3個(gè)工作日內(nèi)審核并發(fā)放，如提交后有刪除簡(jiǎn)歷的行為，視為作弊處理，對(duì)應(yīng)賞金將會(huì)被凍結(jié)不予提現(xiàn)。 4.特別福利：簡(jiǎn)歷完善后既有機(jī)會(huì)直接內(nèi)推給名企噢~ 溫馨提示： 1.如果疑問可以聯(lián)系客服QQ：3413833812 2.一經(jīng)發(fā)現(xiàn)求職者在上傳簡(jiǎn)歷期間有作弊等行為，藥智人才將取消其賞金并凍結(jié)該筆提現(xiàn)。 3.在法律允許的范圍內(nèi)，本活動(dòng)一切解釋權(quán)歸藥智人才 下期活動(dòng)預(yù)告 活動(dòng)日期：5月20-5月24日 賞金金額：更多賺取賞金細(xì)則5月20日揭曉噢~   [更多]

1.Nihon Yakurigaku Zasshi. 2013 Jul;142(1):39-46. doi: 10.1254/fpj.142.39. Pharmacological and clinical properties of AIMIX combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate. 2.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 3.Clin Ther. 2012 Aug;34(8):1705-19. doi: 10.1016/j.clinthera.2012.06.026. Epub 2012 Jul 30. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 4.Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 5.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 6J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053-X. doi: 10.1016/j.jjcc.2019.03.001. [Epub ahead of print] Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR1. 7.Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability 8.Expert Rev Neurother. 2017 Jan;17(1):59-75. Epub 2016 Oct 20. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Tramutola A1, Arena A1,   [更多]